Showing results (31-40 of 135) with videos related to
Sort By:
Pageof 14
Nephrologie & Therapeutique|April 12, 2015
[Drug pharmacokinetics in renal failure: What's new?]Judith Naud, Christopher Dumayne, Thomas D Nolin, et al.The Lancet. Oncology|August 16, 2021
Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participantsMorgan A Casal, S Percy Ivy, Jan H Beumer, et al.Journal of Pharmaceutical and Biomedical Analysis|July 6, 2019
Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney diseaseAlexander J Prokopienko, Raymond E West, Jason R Stubbs, et al.Journal of Clinical Pharmacology|March 5, 2022
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4-Mediated Metabolism of SaxagliptinMorgan A Butrovich, Weifeng Tang, David W Boulton, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2010
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal diseaseThomas D Nolin, Rosemary Ouseph, Jonathan Himmelfarb, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2018
Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine <i>N</i>-Oxide Concentrations in MiceCassandra Johnson, Alexander J Prokopienko, Raymond E West, et al.Journal of the American Society of Nephrology : JASN|August 11, 2006
Hemodialysis acutely improves hepatic CYP3A4 metabolic activityThomas D Nolin, Kofi Appiah, Scott A Kendrick, et al.Journal of Chromatographic Science|December 15, 2015
Validation and Application of a Simple UHPLC-MS-MS Method for the Enantiospecific Determination of Warfarin in Human UrineOsama Y Alshogran, Andrew J Ocque, François A Leblond, et al.Clinical Pharmacology and Therapeutics|December 10, 2003
Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studiesThomas D Nolin, Marc R Gastonguay, Robert R Bies, et al.BMC Nephrology|December 21, 2014
Determination of vancomycin and gentamicin clearance in an in vitro, closed loop dialysis systemSoo Min Jang, Katie E Cardone, Thomas D Nolin, et al.Pageof 14